SOOTHE-A-STING

Manufacturer: Afassco Inc
Effective date: 2019-12-23
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 23:02:18

Label at a glance#

ProductSOOTHE-A-STING

Active ingredientALCOHOL, BENZOCAINE

Label structure10 sections

Indications and uses

temporary relief of pain and itching caused by insect bites and stings

Dosage and administration

spread an even layer of Sting Relief over affected area not mor than 3 to 4 times daily. for children under 2 years of age consult a physician

Contacts and useful links#

PhoneLabel contact800-441-6774

Label contents#

Full prescribing information#

Drug FactsActive Ingredients

OTC - ACTIVE INGREDIENT SECTION

Ethyl alcohol 50.0%

Benzocaine 2.0%

Purpose

OTC - PURPOSE SECTION

Antiseptic

Topcal pain relief

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

temporary relief of pain and itching caused by insect bites and stings

Do not use

OTC - DO NOT USE SECTION

in large quantites, particularly over raw or blistered areas
near eyes, if this happens rinse thoroughly with water

Warnings

WARNINGS SECTION

For external use only. Flammable. Keep away from fire or flame.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens or persists for more than 7 days or clears up and returns

Directions

DOSAGE & ADMINISTRATION SECTION

spread an even layer of Sting Relief over affected area not mor than 3 to 4 times daily.
for children under 2 years of age consult a physician

Inactive ingredients

INACTIVE INGREDIENT SECTION

purified water

SOOTHE-A-STING product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Afassco: The First Choice In First Aid

SOOTHE-A-STING™ WIPE

NDC # 51532-0315-1

1 premoistened towlette

Manufactured for Afassco::® Minden, NV 89423

800-441-6774

LOT AF70216

EXP 07-01-19

Afassco SootheSting

res

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BENZOCAINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51532-0315-1	2021-01-29	C162847	48780-1	ba0f9c33-2b5a-a910-e053-dadaa90a0b85	Soothe-A-Sting - 0315

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51532-0315-1	SOOTHE-A-STING	1 mL in 1 PACKET	LIQUID	1		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51532-0315	SOOTHE-A-STING (ETHYL ALCOHOL, BENZOCAINE) LIQUID [AFASSCO INC]	2	Legacy NDC, 1 package rows	20191224_d6a22d46-fa5e-4d99-b3c4-3be45063eaf9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

SOOTHE-A-STING
ETHYL ALCOHOL, BENZOCAINE
ALCOHOL
BENZOCAINE
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51532-0315	51532-0315-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ALCOHOL	3K9958V90M	ACTIB
BENZOCAINE	U3RSY48JW5	ACTIB
WATER	059QF0KO0R	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
fe3dab82-9fdb-4bb6-b82d-0223619beb65			d6a22d46-fa5e-4d99-b3c4-3be45063eaf9	2019-12-23	Warnings	Exact identifier spl id: fe3dab82-9fdb-4bb6-b82d-0223619beb65 spl set id: d6a22d46-fa5e-4d99-b3c4-3be45063eaf9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.